1. Pharmacoeconomic Evaluation to Assist Prescription Drug Pricing

   • Robert J. Bonk
   • William F. McGhan

   Guest Editorial 17 November 2012 Pages: 73 - 76

2. Physician Education and Prescribing Costs

   • Heather J. Vosper
   • Timothy C. Frewen

   Leading Article 17 November 2012 Pages: 77 - 84

3. Quality-of-Life Evaluation in Diabetes

   • Christine Eiser
   • John E. Tooke

   Leading Article 17 November 2012 Pages: 85 - 91

4. Economic Impact of Cost-Containment Strategies in Third Party Programmes in the US (Part I )

   • C. Eugene Reeder
   • Earle W. Lingle
   • Susan E. Zetzl

   Review Article 17 November 2012 Pages: 92 - 103

5. Formulary Considerations in Selection of β-Blockers

   • Kimberly C. Yedinak

   Review Article 17 November 2012 Pages: 104 - 121

6. Roxithromycin versus Cefaclor in Lower Respiratory Tract Infection

   • W. Guy Scott
   • Murray W. Tilyard
   • Helen M. Scott

   Original Research Article 17 November 2012 Pages: 122 - 130

7. Clozapine

   • Andrew Fitton
   • Paul Benfield

   Pharmacoeconomic Drug Evaluation 17 November 2012 Pages: 131 - 156